Ilonen, Jorma <br/><br/>
Primary islet autoantibody at initial seroconversion and autoantibodies at diagnosis of type 1 diabetes as markers of disease heterogeneity.  [electronic resource] 

 -  Pediatric diabetes  03 2018 
 - 284-292 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1399-5448 
<br/><br/><label>Standard No.: </label>10.1111/pedi.12545  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Autoantibodies--analysis<br/>Autoimmunity<br/>Biomarkers--blood<br/>Cohort Studies<br/>Diabetes Mellitus, Type 1--blood<br/>Family Health<br/>Female<br/>Finland<br/>Follow-Up Studies<br/>Genetic Predisposition to Disease<br/>Glutamate Decarboxylase--antagonists & inhibitors<br/>Humans<br/>Ikaros Transcription Factor--antagonists & inhibitors<br/>Infant, Newborn<br/>Insulin--chemistry<br/>Kaplan-Meier Estimate<br/>Male<br/>Polymorphism, Single Nucleotide<br/>Receptor, ErbB-3--antagonists & inhibitors<br/>Registries<br/>Seroconversion<br/>Zinc Transporter 8--antagonists & inhibitors